Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis.
Shi T, Malik A, Yang Vom Hofe A, Matuschek L, Mullen M, Lages CS, Kudira R, Singh R, Zhang W, Setchell KDR, Hildeman D, Pasare C, Wagner B, Miethke AG.
Shi T, et al. Among authors: singh r.
Sci Transl Med. 2022 Dec 14;14(675):eabi4354. doi: 10.1126/scitranslmed.abi4354. Epub 2022 Dec 14.
Sci Transl Med. 2022.
PMID: 36516265
Free PMC article.